"Ashley did a lot of self-blaming," mom Bailey Velikaneye, 29, told Newsweek: "To this day, it haunts me to hear her say those words." ...

A new PET scan reliably detects benign tumors in the pancreas, according to research led by Radboud university medical center ...

While many factors, such as age and family history, are beyond our control, we can lower our cancer risk with a healthy diet.

Hepatic artery infusion delivers chemo directly into the liver, and that increases the survival rate by up to 40 percent. Now, doctors at the Cleveland Clinic are using a new non-invasive approach to ...

Breast cancer is the number one cancer among women: more than 2 million cases were diagnosed worldwide in 2022. It is also ...

Planned industry first clinical trial combining BeiGene's checkpoint inhibitor tislelizumab with Indaptus’ broadly targeted, short duration ...

The FDA issued a complete response letter (CRL) to Camurus, dealing a setback to the Swedish drugmaker’s efforts to bring its ...

She had stage IV ovarian cancer, and her chances of survival were grim. This September, more than 10 years later, Polo ...

Under Indaptus' clinical supply agreement with BeiGene, the New York biotechnology company plans to advance human clinical evaluation of its cancer treatment -- called Decoy20, which is being studied ...

Researchers conducted a retrospective analysis to identify the specific population of patients with TNBC that benefited from ...

In addition to receiving my traditional cancer treatments, I also opt for integrative medicines, which have helped my mental ...

Harvard Medical School unveils an AI digital pathology tool that outperforms state-of-the-art deep learning methods, ...